Skip to main content
. 2017 Jul 12;22(10):1169–1177. doi: 10.1634/theoncologist.2017-0020

Figure 2.

image

Mutations in key genes and pathways. Variants are shown in association with the RAF/MEK, PI3K/AKT/mTOR, and DNA damage and repair pathways, as well as others. The upper panel shows patients guided toward matched therapy (blue) or conventional chemotherapy (olive green) and their responses. The right panel indicates a frequency of the variants in each gene.